Historical shareholding details of
Calamos Advisors LLC
holdings in Regeneron Pharmaceuticals, Inc. (REGN)
Monthly changes of
Calamos Advisors LLC
shareholding in Regeneron Pharmaceuticals, Inc.
over the previous
months
Month
|
Name |
Total no. shares held |
Percent Holding |
Mar 31, 2025
|
Calamos Advisors Llc
|
22,823
|
0.02%
|
|
Feb 28, 2025
|
Calamos Advisors Llc
|
22,823
|
0.02%
|
|
Jan 31, 2025
|
Calamos Advisors Llc
|
22,823
|
0.02%
|
|
Dec 31, 2024
|
Calamos Advisors Llc
|
22,658
|
0.02%
|
Dec 31, 2024
|
Calamos Advisors Llc
|
22,823
|
0.02%
|
|
Nov 30, 2024
|
Calamos Advisors Llc
|
13,123
|
0.01%
|
|
Oct 31, 2024
|
Calamos Advisors Llc
|
13,123
|
0.01%
|
|
Sep 30, 2024
|
Calamos Advisors Llc
|
12,135
|
0.01%
|
Sep 30, 2024
|
Calamos Advisors Llc
|
13,421
|
0.01%
|
|
Aug 31, 2024
|
Calamos Advisors Llc
|
13,421
|
0.01%
|
|
Jul 31, 2024
|
Calamos Advisors Llc
|
13,458
|
0.01%
|
|
Jun 30, 2024
|
Calamos Advisors Llc
|
12,433
|
0.01%
|
Jun 30, 2024
|
Calamos Advisors Llc
|
13,912
|
0.01%
|
|
May 31, 2024
|
Calamos Advisors Llc
|
13,912
|
0.01%
|
|
Apr 30, 2024
|
Calamos Advisors Llc
|
14,236
|
0.01%
|
|
Mar 31, 2024
|
Calamos Advisors Llc
|
12,887
|
0.01%
|
Mar 31, 2024
|
Calamos Advisors Llc
|
14,236
|
0.01%
|
|
Feb 29, 2024
|
Calamos Advisors Llc
|
14,246
|
0.01%
|
|
Jan 31, 2024
|
Calamos Advisors Llc
|
14,436
|
0.01%
|
|
Dec 31, 2023
|
Calamos Advisors Llc
|
13,211
|
0.01%
|
Dec 31, 2023
|
Calamos Advisors Llc
|
14,436
|
0.01%
|
|
Nov 30, 2023
|
Calamos Advisors Llc
|
14,436
|
0.01%
|
|
Oct 31, 2023
|
Calamos Advisors Llc
|
14,436
|
0.01%
|
|
Sep 30, 2023
|
Calamos Advisors Llc
|
13,384
|
0.01%
|
Sep 30, 2023
|
Calamos Advisors Llc
|
14,436
|
0.01%
|
|
Aug 31, 2023
|
Calamos Advisors Llc
|
14,436
|
0.01%
|
|
Jul 31, 2023
|
Calamos Advisors Llc
|
14,473
|
0.01%
|
|
Jun 30, 2023
|
Calamos Advisors Llc
|
13,384
|
0.01%
|
Jun 30, 2023
|
Calamos Advisors Llc
|
14,503
|
0.01%
|
|
May 31, 2023
|
Calamos Advisors Llc
|
14,513
|
0.01%
|
|
Mar 31, 2023
|
Calamos Advisors Llc
|
13,384
|
0.01%
|
View all ownership details of Regeneron Pharmaceuticals, Inc.